The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Perella, Jennifer Bice
    Director born in February 1984
    Individual (24 offsprings)
    Officer
    2020-09-21 ~ now
    OF - director → CIF 0
    Mrs Jennifer Bice Perella
    Born in February 1984
    Individual (24 offsprings)
    Person with significant control
    2020-09-21 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 2
    Perella, Davide
    Director born in February 1990
    Individual (20 offsprings)
    Officer
    2020-09-21 ~ now
    OF - director → CIF 0
    Mr Davide Perella
    Born in February 1990
    Individual (20 offsprings)
    Person with significant control
    2020-09-21 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 3
    2-8, Millar Crescent, Edinburgh, Scotland
    Corporate (2 parents, 5 offsprings)
    Net Assets/Liabilities (Company account)
    58,478 GBP2024-09-30
    Person with significant control
    2020-09-22 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 1
  • Johnston, Nicholas Ian
    Director born in June 1984
    Individual (1 offspring)
    Officer
    2020-09-21 ~ 2023-05-19
    OF - director → CIF 0
parent relation
Company in focus

BLACKRIDGE PHARMA LTD

Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Intangible Assets
1,736,358 GBP2023-09-30
1,961,116 GBP2022-09-30
Property, Plant & Equipment
53,887 GBP2023-09-30
89,747 GBP2022-09-30
Fixed Assets - Investments
1,431,898 GBP2023-09-30
1,431,898 GBP2022-09-30
Fixed Assets
3,222,143 GBP2023-09-30
3,482,761 GBP2022-09-30
Total Inventories
106,908 GBP2023-09-30
95,026 GBP2022-09-30
Debtors
464,128 GBP2023-09-30
365,947 GBP2022-09-30
Cash at bank and in hand
100,092 GBP2023-09-30
49,237 GBP2022-09-30
Current Assets
671,128 GBP2023-09-30
510,210 GBP2022-09-30
Net Current Assets/Liabilities
-847,447 GBP2023-09-30
-579,949 GBP2022-09-30
Total Assets Less Current Liabilities
2,374,696 GBP2023-09-30
2,902,812 GBP2022-09-30
Net Assets/Liabilities
-532,986 GBP2023-09-30
-112,870 GBP2022-09-30
Equity
Called up share capital
101 GBP2023-09-30
100 GBP2022-09-30
Retained earnings (accumulated losses)
-533,087 GBP2023-09-30
-112,970 GBP2022-09-30
Equity
-532,986 GBP2023-09-30
-112,870 GBP2022-09-30
Property, Plant & Equipment - Depreciation rate used
Furniture and fittings
15 GBP2022-10-01 ~ 2023-09-30
Average Number of Employees
292022-10-01 ~ 2023-09-30
272021-10-01 ~ 2022-09-30
Intangible Assets - Gross Cost
Other than goodwill
2,247,581 GBP2023-09-30
2,247,581 GBP2022-09-30
Intangible Assets - Gross Cost
2,247,581 GBP2023-09-30
2,247,581 GBP2022-09-30
Intangible Assets - Accumulated Amortisation & Impairment
Other than goodwill
511,223 GBP2023-09-30
286,465 GBP2022-09-30
Intangible Assets - Accumulated Amortisation & Impairment
511,223 GBP2023-09-30
286,465 GBP2022-09-30
Intangible Assets - Increase From Amortisation Charge for Year
Other than goodwill
224,758 GBP2022-10-01 ~ 2023-09-30
Intangible Assets - Increase From Amortisation Charge for Year
224,758 GBP2022-10-01 ~ 2023-09-30
Intangible Assets
Other than goodwill
1,736,358 GBP2023-09-30
1,961,116 GBP2022-09-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
6,048 GBP2023-09-30
5,300 GBP2022-09-30
Vehicles
23,720 GBP2023-09-30
23,720 GBP2022-09-30
Office equipment
112,030 GBP2023-09-30
106,866 GBP2022-09-30
Property, Plant & Equipment - Gross Cost
141,798 GBP2023-09-30
135,886 GBP2022-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
4,311 GBP2023-09-30
2,503 GBP2022-09-30
Vehicles
14,578 GBP2023-09-30
8,648 GBP2022-09-30
Office equipment
69,022 GBP2023-09-30
34,988 GBP2022-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
87,911 GBP2023-09-30
46,139 GBP2022-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
1,808 GBP2022-10-01 ~ 2023-09-30
Vehicles
5,930 GBP2022-10-01 ~ 2023-09-30
Office equipment
34,034 GBP2022-10-01 ~ 2023-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
41,772 GBP2022-10-01 ~ 2023-09-30
Property, Plant & Equipment
Plant and equipment
1,737 GBP2023-09-30
2,797 GBP2022-09-30
Vehicles
9,142 GBP2023-09-30
15,072 GBP2022-09-30
Office equipment
43,008 GBP2023-09-30
71,878 GBP2022-09-30
Amounts invested in assets
Non-current
1,431,898 GBP2023-09-30
1,431,898 GBP2022-09-30
Other types of inventories not specified separately
106,908 GBP2023-09-30
95,026 GBP2022-09-30
Trade Creditors/Trade Payables
Amounts falling due within one year
472,077 GBP2023-09-30
433,210 GBP2022-09-30
Bank Borrowings/Overdrafts
Amounts falling due within one year
25,000 GBP2022-09-30
Taxation/Social Security Payable
Amounts falling due within one year
67,919 GBP2023-09-30
60,913 GBP2022-09-30
Other Creditors
Amounts falling due within one year
409,330 GBP2023-09-30
451,387 GBP2022-09-30
Accrued Liabilities/Deferred Income
Amounts falling due within one year
37,571 GBP2023-09-30
11,407 GBP2022-09-30
Bank Borrowings/Overdrafts
Amounts falling due after one year
1,724,000 GBP2023-09-30
1,832,000 GBP2022-09-30
Related profiles found in government register
  • BLACKRIDGE PHARMA LTD
    Info
    Registered number SC674799
    Blackrock House, 2-8 Millar Crescent, Edinburgh, Midlothian EH10 5HW
    Private Limited Company incorporated on 2020-09-21 (4 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-20
    CIF 0
  • BLACKRIDGE PHARMA LTD
    S
    Registered number Sc674799
    Blackrock House, 2 -8 Millar Crescent, Edinburgh, Midlothian, Scotland, EH10 5HW
    Limited Company in Register Of Companies, Scotland
    CIF 1
  • BLACKRIDGE PHARMA LTD
    S
    Registered number Sc674799
    Blackrock House, 2-8 Millar Crescent, Edinburgh, Midlothian, Scotland, EH10 5HW
    Limited Company in Register Of Companies, Scotland
    CIF 2 CIF 3
(more)
child relation
Offspring entities and appointments
Active 7
  • 1
    Blackrock House, 2-8 Millar Crescent, Edinburgh, Midlothian, Scotland
    Dissolved corporate (3 parents)
    Equity (Company account)
    1 GBP2022-09-30
    Person with significant control
    2022-06-06 ~ dissolved
    CIF 6 - Ownership of shares – 75% or more → OE
    CIF 6 - Ownership of voting rights - 75% or more → OE
    CIF 6 - Right to appoint or remove directors → OE
  • 2
    Blackrock House, 2-8 Millar Crescent, Edinburgh, Midlothian, Scotland
    Dissolved corporate (3 parents)
    Equity (Company account)
    100 GBP2022-09-30
    Person with significant control
    2021-04-13 ~ dissolved
    CIF 7 - Ownership of shares – 75% or more → OE
    CIF 7 - Ownership of voting rights - 75% or more → OE
    CIF 7 - Right to appoint or remove directors → OE
  • 3
    Blackrock House, 2-8 Millar Crescent, Edinburgh, Midlothian, Scotland
    Dissolved corporate (4 parents)
    Net Assets/Liabilities (Company account)
    1 GBP2023-09-30
    Person with significant control
    2022-06-06 ~ dissolved
    CIF 2 - Ownership of shares – 75% or more → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
    CIF 2 - Right to appoint or remove directors → OE
  • 4
    Blackrock House, 2-8 Millar Crescent, Edinburgh, Midlothian, Scotland
    Dissolved corporate (3 parents)
    Equity (Company account)
    1 GBP2022-09-30
    Person with significant control
    2022-06-06 ~ dissolved
    CIF 5 - Ownership of shares – 75% or more → OE
    CIF 5 - Ownership of voting rights - 75% or more → OE
    CIF 5 - Right to appoint or remove directors → OE
  • 5
    Blackrock House, 2-8 Millar Crescent, Edinburgh, Midlothian, Scotland
    Dissolved corporate (3 parents)
    Equity (Company account)
    1 GBP2022-09-30
    Person with significant control
    2022-06-06 ~ dissolved
    CIF 3 - Ownership of shares – 75% or more → OE
    CIF 3 - Ownership of voting rights - 75% or more → OE
    CIF 3 - Right to appoint or remove directors → OE
  • 6
    Blackrock House, 2 -8 Millar Crescent, Edinburgh, Midlothian, Scotland
    Dissolved corporate (3 parents)
    Equity (Company account)
    1 GBP2022-12-31
    Person with significant control
    2022-06-06 ~ dissolved
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Right to appoint or remove directors → OE
  • 7
    TRANENT PHARMA LTD - 2020-09-21
    Blackrock House, 2-8 Millar Crescent, Edinburgh, Midlothian, Scotland
    Dissolved corporate (3 parents)
    Equity (Company account)
    1 GBP2022-09-30
    Person with significant control
    2022-06-06 ~ dissolved
    CIF 4 - Ownership of shares – 75% or more → OE
    CIF 4 - Ownership of voting rights - 75% or more → OE
    CIF 4 - Right to appoint or remove directors → OE

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.